This article was originally published in The Gray Sheet
Igen hires Goldman Sachs as strategic advisor, heightening pressure on Roche as the firms discuss a possible settlement of patent litigation and Igen weighs options to maximize shareholder value - including other development partners for Igen's Origen diagnostics technology. Gaithersburg, Maryland-based Igen was awarded $505 mil. by a Maryland federal court in January after Igen filed suit in 1997, charging Roche with breaching an Origen license agreement (1"The Gray Sheet" Jan. 14, 2002, p. 31.) Roche, which said it would appeal the decision, confirms that settlement talks are ongoing...
You may also be interested in...
Igen International will gain the rights to Roche Diagnostic's Elecsys diagnostic product line under a $505 mil. verdict reached Jan. 10 in Maryland federal court
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.